ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $130,172 | -22.5% | 166,888 | -8.1% | 0.00% | – |
Q2 2023 | $167,980 | +309.1% | 181,600 | +545.7% | 0.00% | – |
Q4 2022 | $41,064 | -86.0% | 28,126 | -83.7% | 0.00% | – |
Q2 2022 | $293,000 | -27.7% | 172,312 | -12.4% | 0.00% | – |
Q1 2022 | $405,000 | -72.2% | 196,807 | -49.3% | 0.00% | – |
Q4 2021 | $1,456,000 | -33.2% | 388,376 | -7.9% | 0.00% | – |
Q3 2021 | $2,181,000 | +123.0% | 421,914 | +83.8% | 0.00% | – |
Q2 2021 | $978,000 | -39.4% | 229,610 | -24.4% | 0.00% | – |
Q1 2021 | $1,613,000 | -63.5% | 303,744 | -63.0% | 0.00% | – |
Q4 2020 | $4,422,000 | +102.3% | 821,002 | +199.7% | 0.00% | – |
Q3 2020 | $2,186,000 | -50.9% | 273,900 | -38.5% | 0.00% | -100.0% |
Q2 2020 | $4,455,000 | +33.1% | 445,100 | +80.4% | 0.00% | – |
Q3 2018 | $3,346,000 | +157.6% | 246,763 | +125.4% | 0.00% | – |
Q2 2018 | $1,299,000 | -40.1% | 109,500 | -43.3% | 0.00% | – |
Q1 2018 | $2,168,000 | +715.0% | 193,105 | +385.2% | 0.00% | – |
Q4 2017 | $266,000 | +212.9% | 39,800 | +282.7% | 0.00% | – |
Q3 2017 | $85,000 | +30.8% | 10,400 | -34.8% | 0.00% | – |
Q4 2016 | $65,000 | -50.4% | 15,941 | +47.0% | 0.00% | – |
Q4 2015 | $131,000 | – | 10,844 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |